U.S. flag

An official website of the United States government

NM_000441.2(SLC26A4):c.707T>C (p.Leu236Pro) AND SLC26A4-related disorder

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Sep 21, 2018
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004528073.3

Allele description [Variation Report for NM_000441.2(SLC26A4):c.707T>C (p.Leu236Pro)]

NM_000441.2(SLC26A4):c.707T>C (p.Leu236Pro)

Gene:
SLC26A4:solute carrier family 26 member 4 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q22.3
Genomic location:
Preferred name:
NM_000441.2(SLC26A4):c.707T>C (p.Leu236Pro)
HGVS:
  • NC_000007.14:g.107675051T>C
  • NG_008489.1:g.19417T>C
  • NM_000441.2:c.707T>CMANE SELECT
  • NP_000432.1:p.Leu236Pro
  • NC_000007.13:g.107315496T>C
  • NM_000441.1:c.707T>C
  • O43511:p.Leu236Pro
  • c.707T>C
Protein change:
L236P; LEU236PRO
Links:
UniProtKB: O43511#VAR_007441; OMIM: 605646.0005; dbSNP: rs80338848
Molecular consequence:
  • NM_000441.2:c.707T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
SLC26A4-related disorder
Synonyms:
SLC26A4-related condition; SLC26A4-Related Disorders
Identifiers:

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000916169Illumina Laboratory Services, Illumina
criteria provided, single submitter

(ICSL Variant Classification Criteria 09 May 2019)
Pathogenic
(Sep 21, 2018)
germlineclinical testing

PubMed (8)
[See all records that cite these PMIDs]

Citation Link,

SCV004766575PreventionGenetics, part of Exact Sciences
no assertion criteria provided
Pathogenic
(Feb 15, 2024)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Screening of deafness-causing DNA variants that are common in patients of European ancestry using a microarray-based approach.

Yan D, Xiang G, Chai X, Qing J, Shang H, Zou B, Mittal R, Shen J, Smith RJ, Fan YS, Blanton SH, Tekin M, Morton C, Xing W, Cheng J, Liu XZ.

PLoS One. 2017;12(3):e0169219. doi: 10.1371/journal.pone.0169219.

PubMed [citation]
PMID:
28273078
PMCID:
PMC5342170

Two frequent missense mutations in Pendred syndrome.

Van Hauwe P, Everett LA, Coucke P, Scott DA, Kraft ML, Ris-Stalpers C, Bolder C, Otten B, de Vijlder JJ, Dietrich NL, Ramesh A, Srisailapathy SC, Parving A, Cremers CW, Willems PJ, Smith RJ, Green ED, Van Camp G.

Hum Mol Genet. 1998 Jul;7(7):1099-104.

PubMed [citation]
PMID:
9618166
See all PubMed Citations (8)

Details of each submission

From Illumina Laboratory Services, Illumina, SCV000916169.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (8)

Description

The SLC26A4 c.707T>C (p.Leu236Pro) missense variant is well described in the literature and is one of the three most common pathogenic variants in SLC26A4, which together account for 50% of the disease-causing alleles in probands with Pendred syndrome of northern European descent (Alasti et al. 2014; Tsukada et al. 2015). Across a selection of available literature, the p.Leu236Pro variant has been reported in at least four individuals in a homozygous state, 13 individuals in a compound heterozygous state, and one individual in a heterozygous state, all affected with Pendred syndrome (van Hauwe et al. 1998; Coyle et al. 1998; Campbell et al. 2001). The variant has also been reported in individuals affected with hearing loss, including two in a compound heterozygous state and five in a heterozygous state (Yan et al. 2017). Campbell et al. (2001) demonstrated segregation with disease in at least one multiplex family with temporal bone abnormalities. Haplotype analysis suggests a common founder effect for this variant (van Hauwe et al. 2008; Coyle et al. 1998). The p.Leu236Pro variant was absent from 257 control individuals (van Hauwe et al. 1998; Coyle et al. 1998; Campbell et al. 2001; Yan et al. 2017) and is reported at a frequency of 0.00105 in the European American population of the Exome Sequencing Project. Functional studies by Rotman-Pikielny et al. (2002) demonstrated that the variant protein is retained in the endoplasmic reticulum (ER) whereas the wild type protein targets to the plasma membrane. Yoon et al. (2008) confirmed the initial localization of the p.Leu236Pro variant protein in the ER and showed that after time, the protein was concentrated at the centrosome. They further determined that Cl-/HCO3- ion exchange activity of the variant protein was notably decreased, and that the variant was not temperature sensitive. Based on collective evidence, the p.Leu236Pro variant is classified as pathogenic for SLC26A4-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From PreventionGenetics, part of Exact Sciences, SCV004766575.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The SLC26A4 c.707T>C variant is predicted to result in the amino acid substitution p.Leu236Pro. This variant has been reported to be causative for Pendred syndrome (van Hauwe et al 1998. PubMed ID: 9618166; Campbell et al 2001. PubMed ID: 11317356; Pourová et al 2010. PubMed ID: 20597900). This variant is reported in 0.060% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant is interpreted as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 20, 2026

Modify your search Search (all fields optional) Clear all
Advanced Search